Payment overview · 2025
General Payments
$124.39
5 reported records · 3 companies
Healthcare provider profile · identity verified
Edward A Capone, D.O.
Allopathic & Osteopathic Physicians|Family Medicine · PORT RICHEY, FL · NPI 1396749131
Verified facts
What the public records show
CMS Open Payments records show Edward A Capone, D.O. received $124.39 in general payments during 2025 across 5 reported records.
GlaxoSmithKline, LLC. accounted for 51.5% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| GlaxoSmithKline, LLC. | Unresolved — no canonical attribution shown | $64.06 | 51.5% | 3 | 2025 |
| Biocomposites Inc | Unresolved — no canonical attribution shown | $35.86 | 28.8% | 1 | 2025 |
| Dexcom, Inc. | Unresolved — no canonical attribution shown | $24.47 | 19.7% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $124.39 | 5 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| TRELEGY ELLIPTA Normalized: trelegy ellipta |
Drug | GlaxoSmithKline, LLC. | $64.06 | 3 | 2025 |
Source payment records
|
|||||
| Stimulan Normalized: stimulan |
Device | Biocomposites Inc | $35.86 | 1 | 2025 |
Source payment records
|
|||||
| Dexcom G6 Transmitter Normalized: dexcom g6 transmitter |
Medical Supply | Dexcom, Inc. | $24.47 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 265 | 38 |
| Alprazolam | Alprazolam | 239 | 40 |
| Atorvastatin Calcium | Atorvastatin Calcium | 228 | 50 |
| Levothyroxine Sodium | Levothyroxine Sodium | 205 | 41 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 191 | 47 |
| Pantoprazole Sodium | Pantoprazole Sodium | 178 | 39 |
| Lisinopril | Lisinopril | 143 | 35 |
| Potassium Chloride | Potassium Chloride | 123 | 24 |
| Gabapentin | Gabapentin | 121 | 31 |
| Lorazepam | Lorazepam | 121 | 20 |
| Clonazepam | Clonazepam | 116 | 17 |
| Oxycodone Hcl | Oxycodone Hcl | 116 | 24 |
| Amlodipine Besylate | Amlodipine Besylate | 115 | 29 |
| Metformin Hcl | Metformin Hcl | 98 | 22 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 98 | 21 |
| Sertraline Hcl | Sertraline Hcl | 98 | 23 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 95 | 19 |
| Tramadol Hcl | Tramadol Hcl | 90 | 21 |
| Losartan Potassium | Losartan Potassium | 87 | 26 |
| Bumetanide | Bumetanide | 81 | 13 |
| Simvastatin | Simvastatin | 79 | 16 |
| Ibuprofen | Ibuprofen | 77 | 22 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 77 | 22 |
| Trazodone Hcl | Trazodone Hcl | 76 | 16 |
| Clonidine Hcl | Clonidine Hcl | 74 | 13 |
| Morphine Sulfate Er | Morphine Sulfate | 74 | 12 |
| Diazepam | Diazepam | 73 | 14 |
| Omeprazole | Omeprazole | 73 | 17 |
| Prednisone | Prednisone | 68 | 27 |
| Eliquis | Apixaban | 64 | 14 |
| Furosemide | Furosemide | 64 | 20 |
| Fluticasone Propionate | Fluticasone Propionate | 63 | 17 |
| Pregabalin | Pregabalin | 63 | 11 |
| Zolpidem Tartrate | Zolpidem Tartrate | 61 | 15 |
| Celecoxib | Celecoxib | 59 | 13 |
| Metoprolol Succinate | Metoprolol Succinate | 59 | 14 |
| Ropinirole Hcl | Ropinirole Hcl | 58 | suppressed |
| Tamsulosin Hcl | Tamsulosin Hcl | 58 | 17 |
| Azithromycin | Azithromycin | 57 | 40 |
| Meloxicam | Meloxicam | 57 | 13 |
| Metoprolol Tartrate | Metoprolol Tartrate | 57 | 16 |
| Nystatin | Nystatin | 57 | 12 |
| Duloxetine Hcl | Duloxetine Hcl | 54 | suppressed |
| Clopidogrel | Clopidogrel Bisulfate | 50 | 14 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 50 | 11 |
| Mirtazapine | Mirtazapine | 49 | 13 |
| Atenolol | Atenolol | 48 | 16 |
| Buprenorphine-Naloxone | Buprenorphine Hcl/Naloxone Hcl | 48 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 48 | 16 |
| Famotidine | Famotidine | 44 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 44 | 19 |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 42 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 41 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 40 | 13 |
| Diclofenac Sodium | Diclofenac Sodium | 39 | 13 |
| Oxybutynin Chloride | Oxybutynin Chloride | 39 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 37 | suppressed |
| Temazepam | Temazepam | 37 | suppressed |
| Levemir Flexpen | Insulin Detemir | 36 | suppressed |
| Ozempic | Semaglutide | 36 | suppressed |
| Sucralfate | Sucralfate | 35 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 34 | suppressed |
| Carvedilol | Carvedilol | 34 | suppressed |
| Ondansetron Odt | Ondansetron | 34 | 12 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 33 | suppressed |
| Baclofen | Baclofen | 32 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 32 | 17 |
| Promethazine Hcl | Promethazine Hcl | 32 | suppressed |
| Cefdinir | Cefdinir | 31 | 18 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 31 | 12 |
| Hydrochlorothiazide | Hydrochlorothiazide | 29 | suppressed |
| Lovastatin | Lovastatin | 29 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 29 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 28 | suppressed |
| Methylprednisolone | Methylprednisolone | 28 | 19 |
| Mupirocin | Mupirocin | 28 | 16 |
| Pravastatin Sodium | Pravastatin Sodium | 28 | suppressed |
| Dexamethasone | Dexamethasone | 27 | 23 |
| Fluconazole | Fluconazole | 27 | 12 |
| Januvia | Sitagliptin Phosphate | 27 | suppressed |
| Olanzapine | Olanzapine | 27 | suppressed |
| Xarelto | Rivaroxaban | 27 | suppressed |
| Piroxicam | Piroxicam | 26 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 25 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 25 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 24 | suppressed |
| Carisoprodol | Carisoprodol | 24 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 24 | suppressed |
| Lidocaine | Lidocaine | 24 | suppressed |
| Buprenorphine Hcl | Buprenorphine Hcl | 23 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 23 | suppressed |
| Estradiol | Estradiol | 23 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 23 | suppressed |
| Mounjaro | Tirzepatide | 22 | suppressed |
| Amoxicillin | Amoxicillin | 21 | 12 |
| Nitroglycerin | Nitroglycerin | 21 | suppressed |
| Tetracycline Hcl | Tetracycline Hcl | 21 | suppressed |
| Acyclovir | Acyclovir | 20 | suppressed |
| Cephalexin | Cephalexin | 20 | 18 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 20 | 16 |
| Levofloxacin | Levofloxacin | 20 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 20 | suppressed |
| Ssd | Silver Sulfadiazine | 20 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 20 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 19 | suppressed |
| Allopurinol | Allopurinol | 19 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 19 | 14 |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 19 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 19 | suppressed |
| Ezetimibe | Ezetimibe | 19 | suppressed |
| Latanoprost | Latanoprost | 19 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 19 | suppressed |
| Methadone Hcl | Methadone Hcl | 19 | suppressed |
| Spironolactone | Spironolactone | 19 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 18 | suppressed |
| Naproxen | Naproxen | 18 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 18 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 17 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 16 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 16 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 16 | suppressed |
| Glipizide | Glipizide | 15 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 14 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 14 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 14 | suppressed |
| Pilocarpine Hcl | Pilocarpine Hcl | 14 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 14 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 13 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 13 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 13 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 12 | suppressed |
| Levetiracetam | Levetiracetam | 12 | suppressed |
| Methocarbamol | Methocarbamol | 12 | suppressed |
| Rybelsus | Semaglutide | 12 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 12 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 11 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 11 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 11 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 11 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 11 | suppressed |
| Nifedipine Er | Nifedipine | 11 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 11 | suppressed |
| Nystop | Nystatin | 11 | suppressed |
| Sotalol | Sotalol Hcl | 11 | suppressed |
| Suboxone | Buprenorphine Hcl/Naloxone Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $124.39 · 5 records | GlaxoSmithKline, LLC. | Dexcom G6 Transmitter, Stimulan, TRELEGY ELLIPTA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error